Clinical value of surfactant protein-A in serum and sputum for pulmonary tuberculosis diagnosis

Genetics and Molecular Research

Volumn 12, Issue 4, 2013, Pages 4918-4924

  Hu, H ^a   Teng, G L ^a   Gai, L Z ^a   Yang, Y ^a   Zhu, C J ^a  

^a Department of Cardiology   (China)

Author keywords

Diagnosis; Pulmonary; Sputum; Surfactant protein A; Tuberculosis

Indexed keywords

BACTERIUM ANTIBODY; SURFACTANT PROTEIN A; TUBERCULIN;

ADULT; AGE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LUNG CAVITY; LUNG TUBERCULOSIS; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NONHUMAN; PROTEIN BLOOD LEVEL; SPUTUM; BLOOD; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; RISK FACTORS; SPUTUM; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84887316148     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.October.24.2     Document Type: Article

References (25)

1. Anonymous (1983). Plan of action for research in the immunology of tuberculosis: memorandum from a WHO meeting. Bull. World Health Organ 61: 779-785.
2. Bloom BR and Murray CJ (1992). Tuberculosis: commentary on a reemergent killer. Science 257: 1055-1064.
3. Bobak DA, Gaither TA, Frank MM and Tenner AJ (1987). Modulation of FcR function by complement: subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages. J. Immunol. 138: 1150-1156.
4. Clark H and Reid K (2003). The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysema. Arch. Dis. Child. 88: 981-984.
5. Gold JA, Hoshino Y, Tanaka N, Rom WN, et al. (2004). Surfactant protein A modulates the inflammatory response in macrophages during tuberculosis. Infect. Immun. 72: 645-650.
6. Hawgood S (1989). Pulmonary surfactant apoproteins: a review of protein and genomic structure. Am. J. Physiol. 257: L13-L22.
7. Hawgood S and Shiffer K (1991). Structures and properties of the surfactant-associated proteins. Annu. Rev. Physiol. 53: 375-394.
8. Ikegami M, Carter K, Bishop K, Yadav A, et al. (2006). Intratracheal recombinant surfactant protein d prevents endotoxin shock in the newborn preterm lamb. Am. J. Respir. Crit. Care Med. 173: 1342-1347.
9. Inase N, Ohtani Y, Sumi Y, Umino T, et al. (2006). A clinical study of hypersensitivity pneumonitis presumably caused by feather duvets. Ann. Allergy Asthma Immunol. 96: 98-104.
10. Jobe A, Ikegami M, Jacobs H, Jones S, et al. (1983). Permeability of premature lamb lungs to protein and the effect of surfactant on that permeability. J. Appl. Physiol. 55: 169-176.
11. Kankavi O (2006). Increased expression of surfactant protein A and D in rheumatoid arthritic synovial fluid (RASF). Croat. Med. J. 47: 155-161.
12. McNeely TB and Coonrod JD (1994). Aggregation and opsonization of type A but not type B Hemophilus influenzae by surfactant protein A. Am. J. Respir. Cell Mol. Biol. 11: 114-122.
13. Nadesalingam J, Reid KB and Palaniyar N (2005). Collectin surfactant protein D binds antibodies and interlinks innate and adaptive immune systems. FEBS Lett. 579: 4449-4453.
14. Raviglione MC, Snider DE, Jr. and Kochi A (1995). Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 273: 220-226.
15. Read C (1996). Mycobacterium tuberculosis: a stowaway in the cell. Lancet 348: 50.
16. Sorensen GL, Husby S and Holmskov U (2007). Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology 212: 381-416.
17. Takahashi H, Shiratori M, Kanai A, Chiba H, et al. (2006). Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D. Respirology 11 Suppl: S51-S54.
18. Tenner AJ, Robinson SL, Borchelt J and Wright JR (1989). Human pulmonary surfactant protein (SP-A), a protein structurally homologous to C1q, can enhance FcR-and CR1-mediated phagocytosis. J. Biol. Chem. 264: 13923-13928.
19. van Iwaarden JF, van Strijp JA, Ebskamp MJ, Welmers AC, et al. (1991). Surfactant protein A is opsonin in phagocytosis of herpes simplex virus type 1 by rat alveolar macrophages. Am. J. Physiol. 261: L204-L209.
20. Vazquez de Lara L, Becerril C, Montano M, Ramos C, et al. (2000). Surfactant components modulate fibroblast apoptosis and type I collagen and collagenase-1 expression. Am. J. Physiol. Lung Cell Mol. Physiol. 279: L950-L957.
21. Vazquez de Lara LG, Umstead TM, Davis SE and Phelps DS (2003). Surfactant protein A increases matrix metalloproteinase-9 production by THP-1 cells. Am. J. Physiol. Lung Cell Mol. Physiol. 285: L899-L906.
22. Voss T, Eistetter H, Schafer KP and Engel J (1988). Macromolecular organization of natural and recombinant lung surfactant protein SP 28-36. Structural homology with the complement factor C1q. J. Mol. Biol. 201: 219-227.
23. Weikert LF, Lopez JP, Abdolrasulnia R, Chroneos ZC, et al. (2000). Surfactant protein A enhances mycobacterial killing by rat macrophages through a nitric oxide-dependent pathway. Am. J. Physiol. Lung Cell Mol. Physiol. 279: L216-L223.
24. Wright JR (1997). Immunomodulatory functions of surfactant. Physiol. Rev. 77: 931-962.
25. Wu YZ, Manevich Y, Baldwin JL, Dodia C, et al. (2006). Interaction of surfactant protein A with peroxiredoxin 6 regulates phospholipase A2 activity. J. Biol. Chem. 281: 7515-7525.